DOCSLIB.ORG

Lactic Acid Bacteria As Probiotics for the Nose?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lactic Acid Bacteria As Probiotics for the Nose? bs_bs_banner Minireview Lactic acid bacteria as probiotics for the nose? Ilke De Boeck,1 Irina Spacova,1 evidence for oral or topical probiotics for common Olivier M. Vanderveken2,3 and Sarah Lebeer1* URT diseases such as chronic rhinosinusitis (CRS) 1Department of Bioscience Engineering, University of needs further substantiation. Antwerp, Groenenborgerlaan 171, Antwerp, B-2020, Belgium. 2ENT, Head and Neck Surgery and Communication Introduction Disorders, Antwerp University Hospital, Edegem, Inflammatory upper respiratory tract (URT) diseases Belgium. such as rhinitis, and acute and chronic rhinosinusitis 3Faculty of Medicine and Health Sciences, Translational (CRS), impose a major burden on public health and Neurosciences, University of Antwerp, Antwerp, Belgium. account for significant healthcare costs (Meltzer, 2016; Hellings et al., 2017). Rhinitis is the most common URT disease defined as symptomatic inflammation of the lin- Summary ing of the nose that is caused by infectious agents, aller- Several studies have recently pointed towards an gens or other factors (e.g., drugs and hormones) increased occurrence and prevalence of several taxa (Bousquet et al., 2008). Allergic rhinitis (AR) represents of the lactic acid bacteria (LAB) in the microbiota of the most commonly encountered type of non-infectious the upper respiratory tract (URT) under healthy con- rhinitis, while the term rhinosinusitis is defined as inflam- ditions versus disease. These include several spe- mation of the nose and paranasal sinuses, characterized cies of the Lactobacillales such as Lacticaseibacillus by two or more symptoms, one of which should be either casei, Lactococcus lactis and Dolosigranulum nasal obstruction or nasal discharge (Fokkens et al., pigrum. In addition to physiological studies on their 2020). When the latter condition lasts for more than potential beneficial functions and their long history 12 weeks, it is defined as chronic rhinosinusitis (CRS) of safe use as probiotics in other human body sites, (Fokkens et al., 2020). These disorders have in common LAB are thus increasingly to be explored as alterna- that inflammation, and sometimes also a disruption of tive or complementary treatment for URT diseases. the nasal epithelial barrier, underlie the pathology. In This review highlights the importance of lactic acid addition, a disbalance of the microbial communities or bacteria in the respiratory tract and their potential as dysbiosis inhabiting the airways, the ‘airway microbiota’, topical probiotics for this body site. We focus on the has been suggested as a key factor in the pathology of potential probiotic properties and adaptation factors these URT diseases. that are needed for a bacterial strain to optimally exert its beneficial activity in the respiratory tract. Dysbiosis in URT diseases Furthermore, we discuss a range of in silico, in vitro and in vivo models needed to obtain better insights Recent research shows that a balanced airway micro- into the efficacy and adaptation factors specifically biota plays an important gatekeeper role for respiratory for URT probiotics. Such knowledge will facilitate health, as reviewed by (Man et al., 2017), although it is optimal strain selection in order to conduct rigorous yet very difficult to determine what defines a balanced clinical studies with the most suitable probiotic microbiota. It is generally seen as the counterpart of dys- strains. Despite convincing evidence from micro- biosis. Such an imbalance in the composition and meta- biome association and in vitro studies, the clinical bolic activity of our microbiota can appear in several manners, for example as a loss of beneficial microorgan- Received 20 October, 2020; revised 4 January, 2021; accepted 7 isms, or an excessive growth of potential pathobionts January, 2021. (Wilkins et al., 2019). The identification of beneficial ver- *For correspondence. E-mail [email protected]; Tel. +32 sus potential pathobionts is not always straightforward. 2 653 285. Microbial Biotechnology (2021) 0(0), 1–11 Bacterial genera that are commonly abundant in the doi:10.1111/1751-7915.13759 URT of healthy individuals, without clear symptoms, ª 2021 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. 2 I. De Boeck et al. belong to Staphylococcus, Corynebacterium, Propioni- recently that we start to explore the potential for other bacterium, Dolosigranulum and Streptococcus species applications. Yet, the definition of probiotics, as formu- (Man et al., 2017; Kumpitsch et al., 2019). These taxa lated by an expert panel of the International Scientific can thus be seen to contain potential beneficial strains. Association on Probiotics and Prebiotics (ISAPP) is not Pathobionts such as Staphylococcus aureus, Streptococ- limited to gut applications. Probiotics are ‘live microor- cus pneumoniae, Haemophilus influenzae and Moraxella ganisms that, when administered in adequate amounts, catarrhalis appear to be more prevalent or abundant in confer a health benefit on the host’ (Hill et al., 2014). URT diseases (Van Eldere et al., 2014; Duell et al., Most probiotics studied so far are lactic acid bacteria 2016; Mahdavinia et al., 2016; van den Broek et al., (LAB) (order Lactobacillales), with some of the most 2019). In addition to these classic URT pathogens, other promising probiotic strains belonging to the Lactobacil- emerging pathogens, such as Corynebacterium tubercu- laceae family, recently reclassified (Zheng et al., 2020). lostearicum and Stenotrophomonas, have been sug- Lactobacilli are an interesting choice as probiotics, since gested based on microbiome data (Abreu et al., 2012; they have a long history of safe use for over 100 years Chalermwatanachai et al., 2018; Koeller et al., 2018). by people of all ages on a daily basis in dairy products, Nevertheless, it remains highly challenging to investigate fermented foods and food supplements (Salvetti and whether these changes and disruptions in the micro- O’Toole, 2017). Yet, their potential as URT probiotics is biome are either a causality or a consequence. not yet widely considered. Although various treatment options yet exist for CRS and AR, there is a lack of broadly applicable and effec- Lactic acid bacteria have a habitat in the respiratory tract tive treatment approaches (Hellings et al., 2017; Meng et al., 2019). Current options include mainly nasal irriga- In the recent decade, members of LAB, including Lacti- tions with saline solutions, systemic and/or topical corti- caseibacillus, Dolosigranulum and Lactococcus species, costeroid treatment, antihistamines (in AR) (Meng et al., have been described as part of the normal URT micro- 2019), antibiotic treatments (often macrolides because biota of healthy adults and/or children (Bogaert et al., they also have anti-inflammatory actions) and functional 2011; Laufer et al., 2011; Jensen et al., 2013; Ling endoscopic sinus surgery or FESS (in CRS) (Fokkens et al., 2013; Stearns et al., 2015). Lactobacilli are for et al., 2020). The latter surgery has the aim to clear the instance detected in the nasopharynx of Chinese (Ling diseased mucosa, eliminate the infection, relieve the et al., 2013; Gan et al., 2019), Canadian (Stearns et al., obstruction and restore the sinus ventilation (Piromchai 2015), and Belgian individuals (De Boeck et al., 2020) et al., 2013). However, patients do not always respond and the tonsillar crypts of children and adults (Jensen to the current treatment options and patients often et al., 2013). The pilot study by Abreu and colleagues relapse, even after the surgery. For example, CRS was one of the first that reported that certain LAB taxa, patients often receive multiple antibiotic treatments, lead- including Latilactobacillus sakei, was decreased in CRS ing to several disadvantages, such as microbiota disrup- patients, pointing towards a potential benefit for sinus tion and multidrug-resistant bacteria (Szaleniec et al., health. Furthermore, they developed a murine model of 2019). Also for otitis media (OM), the most common sinus infection, where they demonstrated that L. sakei URT infection in children, antibiotic prescription rates are ATCC15521 can protect the sinus mucosa from C. tu- high despite clinical guidelines limiting their use to strict berculostearicum-induced pathogenesis after nasal inoc- indications (reviewed in van den Broek et al., 2019). ulation, using goblet cell hyperplasia and mucin There is thus a clear need for alternative or complemen- hypersecretion as outcome parameters (Abreu et al., tary treatment options for these highly prevalent URT 2012). These results were obtained in a not yet widely diseases. In this review, we will describe the current applied murine model with only small sample sizes knowledge on the potential of lactic acid bacteria as topi- (n = 3) and have to the best of our knowledge not yet cal probiotics for the URT, with a focus on the probiotic been confirmed in larger sample sizes. In our recent properties and adaptation factors that are needed for a microbiome comparison study between healthy controls bacterial strain to exert its beneficial activity in the URT. and CRS patients, various genera of the Lactobacil- In addition, future perspectives and challenges for URT laceae
Load more

Recommended publications
  • Genomic Stability and Genetic Defense Systems in Dolosigranulum Pigrum A
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.16.440249; this version posted April 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genomic Stability and Genetic Defense Systems in Dolosigranulum pigrum a 2 Candidate Beneficial Bacterium from the Human Microbiome 3 4 Stephany Flores Ramosa, Silvio D. Bruggera,b,c, Isabel Fernandez Escapaa,c,d, Chelsey A. 5 Skeetea, Sean L. Cottona, Sara M. Eslamia, Wei Gaoa,c, Lindsey Bomara,c, Tommy H. 6 Trand, Dakota S. Jonese, Samuel Minote, Richard J. Robertsf, Christopher D. 7 Johnstona,c,e#, Katherine P. Lemona,d,g,h# 8 9 aThe Forsyth Institute (Microbiology), Cambridge, MA, USA 10 bDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital 11 Zurich, University of Zurich, Zurich, Switzerland 12 cDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental 13 Medicine, Boston, MA, USA 14 dAlkek Center for Metagenomics & Microbiome Research, Department of Molecular 15 Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA 16 eVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, 17 Seattle, WA, USA 18 fNew England Biolabs, Ipswich, MA, USA 19 gDivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, 20 Boston, MA, USA 21 hSection of Infectious Diseases, Texas Children’s Hospital, Department of Pediatrics, 22 Baylor College of Medicine, Houston, Texas, USA 23 bioRxiv preprint doi: https://doi.org/10.1101/2021.04.16.440249; this version posted April 18, 2021.
    [Show full text]
  • From Genotype to Phenotype: Inferring Relationships Between Microbial Traits and Genomic Components
    From genotype to phenotype: inferring relationships between microbial traits and genomic components Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakult¨at der Heinrich-Heine-Universit¨atD¨usseldorf vorgelegt von Aaron Weimann aus Oberhausen D¨usseldorf,29.08.16 aus dem Institut f¨urInformatik der Heinrich-Heine-Universit¨atD¨usseldorf Gedruckt mit der Genehmigung der Mathemathisch-Naturwissenschaftlichen Fakult¨atder Heinrich-Heine-Universit¨atD¨usseldorf Referent: Prof. Dr. Alice C. McHardy Koreferent: Prof. Dr. Martin J. Lercher Tag der m¨undlichen Pr¨ufung: 24.02.17 Selbststandigkeitserkl¨ arung¨ Hiermit erkl¨areich, dass ich die vorliegende Dissertation eigenst¨andigund ohne fremde Hilfe angefertig habe. Arbeiten Dritter wurden entsprechend zitiert. Diese Dissertation wurde bisher in dieser oder ¨ahnlicher Form noch bei keiner anderen Institution eingereicht. Ich habe bisher keine erfolglosen Promotionsversuche un- ternommen. D¨usseldorf,den . ... ... ... (Aaron Weimann) Statement of authorship I hereby certify that this dissertation is the result of my own work. No other person's work has been used without due acknowledgement. This dissertation has not been submitted in the same or similar form to other institutions. I have not previously failed a doctoral examination procedure. Summary Bacteria live in almost any imaginable environment, from the most extreme envi- ronments (e.g. in hydrothermal vents) to the bovine and human gastrointestinal tract. By adapting to such diverse environments, they have developed a large arsenal of enzymes involved in a wide variety of biochemical reactions. While some such enzymes support our digestion or can be used for the optimization of biotechnological processes, others may be harmful { e.g. mediating the roles of bacteria in human diseases.
    [Show full text]
  • Dolosigranulum Pigrum Modulates Immunity Against SARS-Cov-2 in Respiratory Epithelial Cells
    pathogens Communication Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells Md. Aminul Islam 1,2 , Leonardo Albarracin 1,3 , Vyacheslav Melnikov 4 , Bruno G. N. Andrade 5 , Rafael R. C. Cuadrat 6,7 , Haruki Kitazawa 1,8,* and Julio Villena 1,3,* 1 Food and Feed Immunology Group, Laboratory of Animal Food Function, Graduate School of Agricultural Science, Tohoku University, Sendai 981-8555, Japan; [email protected] (M.A.I.); [email protected] (L.A.) 2 Department of Medicine, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh 3 Laboratory of Immunobiotechnology, Reference Centre for Lactobacilli (CERELA-CONICET), Tucumán 4000, Argentina 4 Gabrichevsky Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia; [email protected] 5 AdaptCentre, Munster Technological University (MTU), T12 P928 Cork, Ireland; [email protected] 6 Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 13125 Berlin, Germany; [email protected] 7 Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, 14558 Nuthetal, Germany 8 Livestock Immunology Unit, International Education and Research Center for Food and Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, Sendai 981-8555, Japan * Correspondence: [email protected] (H.K.); [email protected] (J.V.) Citation: Islam, M..A.; Albarracin, L.; Melnikov, V.; Andrade, B.G.N.; Abstract: In a previous work, we demonstrated that nasally administered Dolosigranulum pigrum Cuadrat, R.R.C.; Kitazawa, H.; 040417 beneficially modulated the respiratory innate immune response triggered by the activation Villena, J.
    [Show full text]
  • Downloaded from NCBI (NZ AGXA00000000.1) And
    bioRxiv preprint doi: https://doi.org/10.1101/678698; this version posted March 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Dolosigranulum pigrum cooperation and competition in human nasal microbiota 2 Silvio D. Brugger1, 2, 3, 10*, Sara M. Eslami2,10, Melinda M. Pettigrew4,10, Isabel F. 3 Escapa2,3,5, Matthew T. Henke6, Yong Kong7 and Katherine P. Lemon2,5,8,9* 4 1Department of Infectious Diseases and Hospital Epidemiology, University Hospital 5 Zurich, University of Zurich, Zurich, Switzerland, CH-8006 6 2The Forsyth Institute (Microbiology), Cambridge, MA, USA, 02142 7 3Department of Oral Medicine, Infection and Immunity, Harvard School of Dental 8 Medicine, Boston, MA, USA, 02115 9 4Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New 10 Haven, 11 CT, USA, 06510 12 5Alkek Center for Metagenomics & Microbiome Research, Department of Molecular 13 Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA 77030 14 6Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical 15 School, Boston, MA, USA, 02115 16 7Department of Molecular Biophysics and Biochemistry and W.M. Keck Foundation 17 Biotechnology Resource Laboratory, Yale University, New Haven, CT, USA, 06519 18 8Division of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, 19 Boston, MA, USA, 02115 1 bioRxiv preprint doi: https://doi.org/10.1101/678698; this version posted March 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Susan Gottesman, Phd National Institutes of Health
    Boston Bacterial Meeting 2017 Crystal structure of Hfq in a complex with sRNA, Keynote speaker: RNA binding interfaces highlighted. Modeled using PDB: 4V2S Susan Gottesman, PhD National Institutes of Health Generously sponsored by: 2017 Boston Bacterial Meeting - Schedule and Introduction Thursday June 15 12:00 pm Registration 12:45 pm Opening Remarks I: Bacterial communities Chair: Matthew Ramsey Stephanie High-throughput analysis of targeted mutant libraries reveals new 1:00 pm Shames Legionella pneumophila effector virulence phenotypes Microbial hitchhiking promotes dispersal and colonization of new niches 1:20 pm Tahoura Samad by staphylococci Interactions between species introduce spurious associations in 1:40 pm Rajita Menon microbiome studies: evidence from inflammatory bowel disease The upper respiratory tract commensal Dolosigranulum pigrum inhibits 2:00 pm Silvio Brugger Staphylococcus aureus 2:20 pm Coffee Break II: Morphogenesis Chair: Eddie Geisinger Determining how bacteria regulate their rate of growth at the single- 2:50 pm Yingjie Sun molecule and single-cell levels by super-resolution microscopy Metabolic control of cell morphogenesis: perturbed TCA cycle halts 3:10 pm Irnov Irnov peptidoglycan biosynthesis Membrane remodeling at the division septum by the bacterial actin 3:30 pm Joseph Conti homolog FtsA 3:50 pm Kristin Little A cell envelope stress response system keeps cells in shape 4:10 pm Poster Session I - Science Center (#1-32, 60-66) III: Treatment strategies Chair: Alex Kostic Sebastien 5:30 pm BRACE for resistance:
    [Show full text]
  • Microbial and Clinical Factors Are Related to Recurrence of Symptoms After Childhood Lower Respiratory Tract Infection
    Early View Original article Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection Emma M. de Koff, Wing Ho Man, Marlies A. van Houten, Arine M. Vlieger, Mei Ling J.N. Chu, Elisabeth A.M. Sanders, Debby Bogaert Please cite this article as: de Koff EM, Man WH, van Houten MA, et al. Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection. ERJ Open Res 2021; in press (https://doi.org/10.1183/23120541.00939-2020). This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Copyright ©The authors 2021. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact [email protected] Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection Emma M. de Koff1,2, Wing Ho Man1,3, Marlies A. van Houten1,4, Arine M. Vlieger5, Mei Ling J.N. Chu2, Elisabeth A.M. Sanders2,6, Debby Bogaert2,7 1. Spaarne Academy, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands 2. Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children’s Hospital and University Medical Centre Utrecht, Utrecht, Netherlands 3. Department of Paediatrics, Willem-Alexander Children’s Hospital and Leiden University Medical Centre, Leiden, Netherlands 4.
    [Show full text]
  • Optimizing Identification of Clinically Relevant Gram-Positive Organisms by Use of the Bruker Biotyper Matrix-Assisted Laser
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital Commons@Becker Washington University School of Medicine Digital Commons@Becker Open Access Publications 2013 Optimizing identification of clinically relevant gram-positive organisms by use of the bruker biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system Erin McElvania TeKippe Washington University School of Medicine in St. Louis Sunni Shuey St. Louis Children's Hospital David W. Winkler St. Louis Children's Hospital Meghan A. Butler St. Louis Children's Hospital Carey-Ann Burnham Washington University School of Medicine in St. Louis Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs Recommended Citation McElvania TeKippe, Erin; Shuey, Sunni; Winkler, David W.; Butler, Meghan A.; and Burnham, Carey-Ann, ,"Optimizing identification of clinically relevant gram-positive organisms by use of the bruker biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system." Journal of Clinical Microbiology.51,5. 1421-1427. (2013). http://digitalcommons.wustl.edu/open_access_pubs/2333 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Optimizing Identification of Clinically Relevant Gram-Positive Organisms by Use of the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization−Time of Flight Mass Spectrometry System Downloaded from Erin McElvania TeKippe, Sunni Shuey, David W. Winkler, Meghan A. Butler and Carey-Ann D. Burnham J. Clin. Microbiol. 2013, 51(5):1421.
    [Show full text]
  • Bacterial Microbiota Analysis Present in the Nose and Pharynx of a Mexican Young Population
    Int.J.Curr.Microbiol.App.Sci (2016) 5(6): 223-235 International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 6 (2016) pp. 223-235 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.506.026 Bacterial Microbiota Analysis Present in the Nose and Pharynx of a Mexican Young Population Ana Karina Rodríguez-Vicente1, Jaime Bustos-Martínez2, Dolores Reyes-Duarte3 and Teresita Sainz-Espuñes4* 1Doctorado en Ciencias Biológicas y de la Salud. Universidad Autónoma Metropolitana-Xochimilco. Mexico City, Mexico 2Departamento de Atención a la Salud. Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico 3Departamento de Procesos y Tecnología. Universidad Autónoma Metropolitana-Cuajimalpa, Mexico City, Mexico 4Departamento de Sistemas Biológicos. Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico *Corresponding author email id: ABSTRACT Culture-independent microbiota is relatively unexplored in Mexican population. The aim of this study was to characterize the microbiota of Mexican young healthy adults by means of K eywo rd s traditional culture and metagenomic analysis in order to provide novel insights and have a better understanding about the healthy baselines from which to detect differences associated Bacterial with diseases. The bacterial microbiota of the nose and pharynx from 75 healthy Microbiota, nonsmoking Mexican young adults was examined by conventional cultures and culture- Nose and independent methods. The hypervariable region (V6-V8) of the16S rRNA gene was PCR Pharynx , amplified from isolated DNA and DGGE analyzed, bands excised were sequenced and metagenomic phylogenetic analys is was done. The study showed that the bacterial microbiota of analysis . the pharynx was richer than that of the nose.
    [Show full text]
  • WO 2015/071474 A2 21 May 2015 (21.05.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/071474 A2 21 May 2015 (21.05.2015) P O P C T (51) International Patent Classification: Krzysztof; Simmeringer Hauptstrasse 45/8, A-1 110 Vi C12N 15/11 (2006.01) enna (AT). FONFARA, Ines; Helmstedter Strasse 144, 38102 Braunschweig (DE). (21) International Application Number: PCT/EP2014/074813 (74) Agent: PILKINGTON, Stephanie Joan; Potter Clarkson LLP, The Belgrave Centre, Talbot Street, Nottingham NG1 (22) International Filing Date: 5GG (GB). 17 November 2014 (17.1 1.2014) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (30) Priority Data: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 61/905,835 18 November 2013 (18. 11.2013) US HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (71) Applicant: CRISPR THERAPEUTICS AG [CH/CH]; KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, Aeschenvorstadt 36, CH-4051 Basel (CH). MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (72) Inventors: CHARPENTIER, Emmanuelle; Boeckler- SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, strasse 18, 38102 Braunschweig (DE).
    [Show full text]
  • The Microbiome of the Middle Meatus in Healthy Adults
    The Microbiome of the Middle Meatus in Healthy Adults Vijay R. Ramakrishnan1*, Leah M. Feazel2, Sarah A. Gitomer1, Diana Ir2, Charles E. Robertson4, Daniel N. Frank2,3 1 Department of Otolaryngology-Head and Neck Surgery, University of Colorado, Aurora, Colorado, United States of America, 2 Division of Infectious Diseases, University of Colorado, Aurora, Colorado, United States of America, 3 Microbiome Research Consortium, University of Colorado, Aurora, Colorado, United States of America, 4 Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado, United States of America Abstract Rhinitis and rhinosinusitis are multifactorial disease processes in which bacteria may play a role either in infection or stimulation of the inflammatory process. Rhinosinusitis has been historically studied with culture-based techniques, which have implicated several common pathogens in disease states. More recently, the NIH Human Microbiome Project has examined the microbiome at a number of accessible body sites, and demonstrated differences among healthy and diseased patients. Recent DNA-based sinus studies have suggested that healthy sinuses are not sterile, as was previously believed, but the normal sinonasal microbiome has yet to be thoroughly examined. Middle meatus swab specimens were collected from 28 consecutive patients presenting with no signs or symptoms of rhinosinusitis. Bacterial colonization was assessed in these specimens using quantitative PCR and 16S rRNA pyrosequencing. All subjects were positive for bacterial colonization of the middle meatus. Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acnes were the most prevalent and abundant microorganisms detected. Rich and diverse bacterial assemblages are present in the sinonasal cavity in the normal state, including opportunistic pathogens typically found in the nasopharynx.
    [Show full text]
  • 1 Dolosigranulum Pigrum Cooperation and Competition in Human Nasal Microbiota
    bioRxiv preprint doi: https://doi.org/10.1101/678698; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Dolosigranulum pigrum cooperation and competition in human nasal microbiota 2 Silvio D. Brugger1, 2, 3, 8*, Sara M. Eslami2,8, Melinda M. Pettigrew4,8, Isabel F. Escapa2,3, Matthew 3 M. Henke5, Yong Kong6 and Katherine P. Lemon2,7,9* 4 1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 5 University of Zurich, Zurich, Switzerland, CH-8006 6 2The Forsyth Institute (Microbiology), Cambridge, MA, USA, 02142 7 3Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, 8 Boston, MA, USA, 02115 9 4Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, 10 CT, USA, 06510 11 5 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 12 Boston, MA, USA, 02115 13 6Department of Molecular Biophysics and Biochemistry and W.M. Keck Foundation 14 Biotechnology Resource Laboratory, Yale University, New Haven, CT, USA, 06519 15 7Division of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, 16 MA, USA, 02115 17 8These authors contributed equally 18 9Lead Contact 19 *Correspondence: [email protected] and [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/678698; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • The Potential Pathogenicity of Dolosigranulum Pigrum in Multiple Sclerosis, and the Occurrence of the Organism in the Upper Respiratory Tract
    The potential pathogenicity of Dolosigranulum pigrum in multiple sclerosis, and the occurrence of the organism in the upper respiratory tract by Francis Mark Jorge MSc CSci FIBMS CBiol MSB A portfolio of research and development in a professional context Submitted in partial fulfilment of the Degree of Professional Doctorate in Biomedical Science School of Pharmacy and Biomedical Sciences Faculty of Science University of Portsmouth May 2014 Abstract The bacterial toxins hypothesis in multiple sclerosis postulates that bacterial toxins from the human nasopharynx access the central nervous system and are implicated in the disease. Dolosigranulum pigrum was originally found in acute multiple sclerosis tissues. This study seeks to determine if the organism is found in human nasal tracts and explores the relationship between Dolosigranulum pigrum infection and multiple sclerosis by measuring antibody to the bacterium in multiple sclerosis patients and matched controls. Eighty eight clinical specimens were cultured onto blood agar and analysed using rabbit anti-Dolosigranulum pigrum sera, and fluorescein isothiocyanate. None tested positive for Dolosigranulum pigrum. Dolosigranulum pigrum was looked for using a novel polymerase chain reaction test. Thirty samples tested positive, 17 male, 13 female, with an age range from 8 days to 74 years. Twelve were sent for sequencing, seven matched Dolosigranulum pigrum, two showed mixed amplicons and three produced signals not matching Dolosigranulum pigrum. Sixty five multiple sclerosis sera and matched controls were tested for anti- Dolosigranulum pigrum using a novel enzyme linked immunosorbant assay. The multiple sclerosis group showed raised antibodies, significantly different to the controls, p ≤ 0.001. Fifteen of the multiple sclerosis sera and controls were Western blotted.
    [Show full text]